2018 Deals & Portfolio Review

Discover Opportunities & Emerging Trends in Pharma Deal-making

2018 is shaping up to be a year of big dollar deals and blockbuster launches for the life sciences market. Looking back at the year’s trends can help prepare for what is to come in 2019. Clarivate Analytics’s experts are back with the annual Deals and Portfolio Review, providing you with the trends and analysis of the year’s biggest deals and key portfolio activity. Laura Vitez and Jamie Munro will present this exclusive first look live in San Francisco during the week of the 37th J.P. Morgan Healthcare Conference.

Registration is now closed for these sessions.


Laura Vitez
Strategy and M&A
Clarivate Analytics

Laura Vitez has over 20 years of experience in the life sciences industry. She joined the life sciences team at Clarivate Analytics in the fall of 2013 where she currently serves as a member of the Strategy and M&A team. Previously Ms. Vitez held a variety of lead and advisory business development roles with companies including Intellikine, Rinat, Schwarz Pharma, and Cell Genesys. Ms. Vitez has participated in alliances generating more than $2 billion in reported value for her clients and companies.

Jamie Munro
Global Practice Leader, Portfolio & Licensing
Clarivate Analytics

Jamie Munro leads the Portfolio & Licensing practice at Clarivate Analytics including heading up CMR International, the R&D benchmarking service. Dr Munro has significant life science experience including over 15 years large pharma experience as well as a PhD in Finance.

Event details

Venue/ Location:  Each 60 minute session will be held at the Hotel Zetta, a short walk from Union Square

Hotel Zetta
55 Fifth St San Francisco, CA 94103
Map & Directions





Each session will include:



- Overview of deal making activity throughout 2018, as captured by Cortellis data tools.
- Deal dollars and volumes by transaction type, therapeutic area, development stage, keenest buysiders.
- Examination of long term trends versus current developments.

- 2018 Year in Review. A summary of key trends and metrics for innovative pharma and what to
watch out for in 2019.
- Deal-making in the Spotlight. Perspectives on the value of M&A.
- Examination of long term trends versus current developments.

Schedule for each day:

  • 11:00 - 12:00 Deals review session
  • 12:00 - 1:00 Optional networking lunch

What were the Dealmaking trends of 2017?

Get ahead of the game with a free inside look at the highlights of last year's deals review.
Download your copy of the 2017 Executive Summary.

Download now